This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Middle East Respiratory Syndrome-Related Coronavirus Spike Glycoprotein (S), C-His
Product Overview
BioVenic's Recombinant Middle East Respiratory Syndrome-Related Coronavirus Spike Glycoprotein (S), C-His is a recombinant protein expressed from Mammalian Cells. Its predicted molecular weight is NA. The purity is>90% (SDS-PAGE).
Specifications
Target Information
The middle east respiratory syndrome coronavirus spike glycoprotein (S) primarily infects humans but can also infect animals such as camels. In the veterinary field, studying this protein helps understand the virus's infection mechanisms and host range. The S protein mediates viral entry into host cells and is a crucial target for developing vaccines and diagnostic tools. Researching its structure and function provides a scientific basis for preventing and controlling MERS-CoV infections.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.Aliquote the reconstituted solution to minimise freeze-thaw cycles.